Clinical trials
Phase 2 Ischemic Stroke trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2016 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 9 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 9 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 20 |
| Unknown status | 17 |
| Not yet recruiting | 4 |
| Active, not recruiting | 2 |
| Suspended | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tiantan Hospital | 12 |
| General Hospital of Shenyang Military Region | 6 |
| Capital Medical University | 5 |
| Xijing Hospital | 4 |
| Huashan Hospital | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| Shanghai East Hospital | 2 |
| Shanghai Pharmaceuticals Holding Co., Ltd | 2 |
| Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2 |
| Tianjin Medical University General Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 69 |
| Stroke | 14 |
| Brain Diseases | 3 |
| Cerebrovascular Disorders | 2 |
| Inflammation | 2 |
| Angina, Stable | 1 |
| Cardiovascular Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cerebral Infarction | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.